Kevin P. Kerns

Array ( [id] => 5580528 [patent_doc_number] => 20090175874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'NOVEL INTERLEUKIN-1 RECEPTOR INTRACELLULAR LIGAND PROTEINS AND INHIBITORS OF LIGAND BINDING' [patent_app_type] => utility [patent_app_number] => 12/172798 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9713 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175874.pdf [firstpage_image] =>[orig_patent_app_number] => 12172798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84009 [patent_doc_number] => 07741434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'High-affinity antagonists of ELR-CXC chemokines' [patent_app_type] => utility [patent_app_number] => 12/172333 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 23 [patent_no_of_words] => 15248 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741434.pdf [firstpage_image] =>[orig_patent_app_number] => 12172333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 201967 [patent_doc_number] => 07632501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Antibodies against monocyte chemotactic proteins' [patent_app_type] => utility [patent_app_number] => 12/171791 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 9 [patent_no_of_words] => 26499 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632501.pdf [firstpage_image] =>[orig_patent_app_number] => 12171791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6503829 [patent_doc_number] => 20100260744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'REGULATING IL-4 AND IL-13 LEVELS BY BLOCKING HIGH AFFINITY BINDING BY IL-3, IL-5 AND GM-CSF TO THEIR COMMON RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/668123 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20852 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260744.pdf [firstpage_image] =>[orig_patent_app_number] => 12668123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123503 [patent_doc_number] => 07705128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'IL-1-like cytokine' [patent_app_type] => utility [patent_app_number] => 12/166162 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28607 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705128.pdf [firstpage_image] =>[orig_patent_app_number] => 12166162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439173 [patent_doc_number] => 20100279313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Novel secreted immunomodulatory proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/215729 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279313.pdf [firstpage_image] =>[orig_patent_app_number] => 12215729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12283189 [patent_doc_number] => 09931377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Cell expressing complexes of IL-15 and IL-15Ralpha [patent_app_type] => utility [patent_app_number] => 12/666052 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 26 [patent_no_of_words] => 48084 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446015 [patent_doc_number] => 20090047241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'IL-12 FACILITATES BOTH THE RECOVERY OF ENDOGENOUS HEMATOPOIESIS AND THE ENGRAFTMENT OF STEM CELLS AFTER IONIZING RADIATION' [patent_app_type] => utility [patent_app_number] => 12/142146 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9408 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047241.pdf [firstpage_image] =>[orig_patent_app_number] => 12142146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343916 [patent_doc_number] => 20100248256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'HEPATOCELLULAR CARCINOMA PROTEIN MARKER, AND METHOD FOR DETECTION OF HEPATOCELLULAR CARCINOMA USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/452216 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3072 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20100248256.pdf [firstpage_image] =>[orig_patent_app_number] => 12452216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682290 [patent_doc_number] => 20080248516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Method for Using Division Arrested Cells in Screening Assays' [patent_app_type] => utility [patent_app_number] => 12/138218 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3439 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248516.pdf [firstpage_image] =>[orig_patent_app_number] => 12138218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886357 [patent_doc_number] => 20080260689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'PEPTIDES FOR ACTIVE ANTI-CYTOKINE IMMUNIZATION' [patent_app_type] => utility [patent_app_number] => 12/134743 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6482 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260689.pdf [firstpage_image] =>[orig_patent_app_number] => 12134743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385675 [patent_doc_number] => 08263064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Method of suppressing disease severity of multiple sclerosis using chemokine CXC11' [patent_app_type] => utility [patent_app_number] => 12/602771 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 32 [patent_no_of_words] => 17071 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350180 [patent_doc_number] => 20090005541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'GAG BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/131311 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15157 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005541.pdf [firstpage_image] =>[orig_patent_app_number] => 12131311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070146 [patent_doc_number] => 20110044996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'NEUTRALIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/601514 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11306 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044996.pdf [firstpage_image] =>[orig_patent_app_number] => 12601514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236393 [patent_doc_number] => 07595374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-29 [patent_title] => 'Heparin binding motif and use thereof' [patent_app_type] => utility [patent_app_number] => 12/125008 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5375 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595374.pdf [firstpage_image] =>[orig_patent_app_number] => 12125008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586251 [patent_doc_number] => 20090105453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Interleukin-9 receptor mutants' [patent_app_type] => utility [patent_app_number] => 12/116706 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14791 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105453.pdf [firstpage_image] =>[orig_patent_app_number] => 12116706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685457 [patent_doc_number] => 20100120684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'MUTANTS OF INTERLEUKIN- 1 RECEPTOR ANTAGONIST AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/598140 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22278 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120684.pdf [firstpage_image] =>[orig_patent_app_number] => 12598140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353267 [patent_doc_number] => 20100086547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/598309 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8372 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086547.pdf [firstpage_image] =>[orig_patent_app_number] => 12598309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 229017 [patent_doc_number] => 07601830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Polynucleotide encoding mammalian cytokine-like polypeptide-10' [patent_app_type] => utility [patent_app_number] => 12/111798 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15747 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601830.pdf [firstpage_image] =>[orig_patent_app_number] => 12111798 [rel_patent_id] =>[rel_patent_doc_number] =>)